Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Fa Yi Xue Za Zhi ; 34(5): 516-519, 2018 Oct.
Article in English, Chinese | MEDLINE | ID: mdl-30468055

ABSTRACT

OBJECTIVES: To identify the drop-off location of victims in drowning cases, and confirm whether it is a fatal drowning or the victim is thrown into the water after death by detecting part of 5.8S sequence and second internal transcribed spacer (ITS2) (5.8S+ITS2) of diatom rDNA in water and organs. METHODS: Two cases identified by diatom examination, which received by Nanjing Municipal Public Security Bureau Forensic Center, were taken as the research objects. The difference of the population structure of algae in water and human tissue was analysed by length polymorphism of 5.8S+ITS2 marker. RESULTS: In case 1, similar species of diatom were detected from victim's lung and liver tissues and the water sample. Two kinds of DNA fragments with length of 330 bp and 376 bp were detected from victim's lung tissue and the water sample using 5.8S+ITS2 marker, which could confirm the victim was drowning before death. In case 2, there was no diatom found in victim's lung and liver tissues. Only one kind of DNA fragment with length of 331 bp and low relative fluorescence unit (RFU) was obtained from victim's lung tissue using 5.8S+ITS2 marker, thus the victim was thrown into the water after death. CONCLUSIONS: The experimental results of the two cases in present study are consistent with the actual facts and the result of the diatom microscopic examination. The difference of population structure of specific microorganism in water and human tissue can be detected by 5.8S+ITS2 marker, which can help to identify the drop-off location of victims in drowning cases, and confirm whether it is a fatal drowning or the victim is thrown into the water after death.


Subject(s)
DNA, Ribosomal , Diatoms , Drowning , DNA, Ribosomal/analysis , Diatoms/genetics , Drowning/diagnosis , Humans , Liver , Lung
2.
Water Sci Technol ; 50(6): 173-8, 2004.
Article in English | MEDLINE | ID: mdl-15537005

ABSTRACT

Control of nutrients as nitrogen and phosphorus after discharge into lakes is necessary since it is difficult and costly to control within wastewater plants currently in China. This paper studied the cycling of phosphorus and nitrogen with water and sediments from two lakes in China. It is found that oxygen plays a critical role in regulating phosphorus and nitrogen cycling within water and sediments. Three different oxygenation methods including aeration, calcium peroxide and hydrogen peroxide were studied to control phosphorus and nitrogen in overlying water. In anoxic conditions, the P concentration in water increased from an average 14 microg/L to 115.2 microg/L for Xili Lake, and from an average 24 microg/L to 1,000 microg/L for Jinchun Lake. The concentration of ammonia increased under anoxic conditions, while the concentration of nitrate increased under oxic conditions. In anoxic conditions, the nitrate concentration decreased probably through denitrification. Both N and P accumulation processes can be controlled under the three treatments. The phosphorus removal efficiency from the water body was in the order of CaO2 addition > aeration > H2O2 addition, while controlling effectiveness for ammonia was in the order of aeration > CaO2 addition > H2O2 addition.


Subject(s)
Bioreactors , Ecosystem , Fresh Water/chemistry , Nitrogen/isolation & purification , Waste Disposal, Fluid/methods , Ammonia/isolation & purification , Bacteria, Aerobic/metabolism , China , Fresh Water/microbiology , Hydrogen Peroxide/metabolism , Hydrogen-Ion Concentration , Hypoxia/metabolism , Nitrites/chemistry , Nitrites/metabolism , Nitrogen/metabolism , Oxygen/metabolism , Peroxides/metabolism , Phosphorus/isolation & purification , Time Factors
3.
Clin Ther ; 21(8): 1301-12, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10485502

ABSTRACT

DFP [3-(2-propyloxy)-(4-methyl-sulfonylphenyl)-(5,5-dimethyl)-fu ranone] is a highly specific cyclooxygenase-2 inhibitor (>2500-fold selective in transfected Chinese hamster ovary cell assays) that has demonstrated efficacy in preclinical models of pain and inflammation. The present single-dose, randomized, double-masked, double-dummy, placebo-controlled, parallel-group study was undertaken to compare DFP 5, 25, and 50 mg with naproxen sodium 550 mg and with placebo in 196 patients (mean age, 25.8 years; 187 [95.4%] males) who experienced moderate-to-severe pain after surgical removal of > or =2 third molars. Overall analgesic effect, duration of effect, time to onset of analgesic effect, peak analgesic effect, and tolerability were assessed over a 24-hour postdose period. Both DFP 25 and 50 mg, as well as the active comparator, naproxen sodium 550 mg, were significantly more effective than placebo. The onset of analgesic effect in the DFP 25-mg, DFP 50-mg, and naproxen sodium 550-mg groups did not differ significantly. DFP was generally well tolerated in single doses up to 50 mg. DFP 50 mg was efficacious in the treatment of postoperative dental pain and was indistinguishable from the active comparator, naproxen sodium 550 mg.


Subject(s)
Isoenzymes/metabolism , Isoflurophate/adverse effects , Isoflurophate/therapeutic use , Naproxen/therapeutic use , Pain, Postoperative/drug therapy , Prostaglandin-Endoperoxide Synthases/metabolism , Tooth Extraction/adverse effects , Adult , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/adverse effects , Cyclooxygenase Inhibitors/therapeutic use , Double-Blind Method , Female , Humans , Male , Membrane Proteins , Naproxen/adverse effects , Protease Inhibitors/adverse effects , Protease Inhibitors/therapeutic use , Time Factors
4.
Br J Sports Med ; 28(2): 112-6, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7921910

ABSTRACT

Ankle sprain is a common sports injury and is often regarded as trivial by athletes and coaches. This epidemiological study was conducted among three categories of Hong Kong Chinese athletes: national teams, competitive athletes and recreational athletes. This study shows that as much as 73% of all athletes had recurrent ankle sprain and 59% of these athletes had significant disability and residual symptoms which led to impairment of their athletic performance. This study indicates that a proper approach towards injury prevention and a comprehensive rehabilitation programme are required.


Subject(s)
Ankle Injuries/epidemiology , Athletic Injuries/epidemiology , Sprains and Strains/epidemiology , Adolescent , Adult , Ankle Injuries/complications , Athletic Injuries/complications , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Recurrence , Sprains and Strains/complications
5.
J Am Soc Nephrol ; 1(3): 257-65, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2104269

ABSTRACT

A rabbit model of renal glomerulosclerosis induced by anti-glomerular basement membrane antibody was used to determine whether colchicine would protect renal function and reduce fibrosis. Initial studies established the time course of renal function changes and fibrosis. Colchicine at a dose of 0.02 to 0.04 mg/kg per day injected ip was begun at day 4 when injury had been initiated, and the experiment was ended at day 21 when fibrotic changes were established. Colchicine significantly reduced the rise in serum creatinine (serum creatinine = 2.7 +/- 0.3 mg% in vehicle-treated animals versus 1.8 +/- 0.1 mg% in colchicine-treated animals) and interstitial fibrosis (fibrosis score = 2.6 +/- 0.2 in vehicle-treated versus 1.5 +/- 0.2 in colchicine-treated animals). Colchicine treatment did not significantly affect weight, anti-guinea pig immunoglobulin level, % fibrocellular crescents formed, hydroxyproline per gram (dry weight) in tissue, or urine protein: creatine ratio. Regression analysis was performed to examine the interrelationships between variables for all animals and the effect of colchicine on pairs of variables. No clear-cut site of colchicine action could be identified. These data show that colchicine, in doses that could be used in humans, protected renal function by about 25% and reduced interstitial fibrosis in a model of severe crescentic nephritis.


Subject(s)
Colchicine/therapeutic use , Glomerulonephritis/drug therapy , Animals , Basement Membrane/immunology , Creatinine/blood , Fibrosis , Glomerulonephritis/pathology , Glomerulonephritis/physiopathology , Guinea Pigs , Hydroxyproline/metabolism , Kidney Glomerulus/immunology , Rabbits
6.
Respiration ; 56(1-2): 22-33, 1989.
Article in English | MEDLINE | ID: mdl-2602668

ABSTRACT

The principal clinical pulmonary findings were extracted from University of Michigan Hospital records of 390 patients with scleroderma. Dyspnea was the most frequent symptom and strongly correlated with pulmonary fibrosis and with decreased vital capacity (FVC) and CO diffusing capacity (DLCO). The mean value for FVC was 84% of the predicted normal for 326 patients, and that of the initial DLCO 56.8% of the predicted normal (323 patients). Pulmonary fibrosis was diagnosed on first chest X-ray in 80 of 382 patients. An additional 48 patients developed fibrosis detected on subsequent X-rays. Analyses were performed to determine whether the deterioration of pulmonary function over time was less for scleroderma patients who were adequately treated with potassium p-aminobenzoate (KPAB) than for those inadequately or never treated with KPAB, The average decrease for both FVC and DLCO was found to be less for KPAB-treated patients. However, only in the case of vital capacity was the difference significant. In the presence of radiological evidence of pulmonary fibrosis FVC decreased more rapidly (p = 0.002), but the decline in DLCO was not affected. When adjusting for the presence or absence of fibrosis the average slopes of the logarithm of vital capacity were significantly less negative (p = 0.003) for patients on KPAB.


Subject(s)
4-Aminobenzoic Acid/therapeutic use , Pulmonary Fibrosis/drug therapy , Scleroderma, Systemic/physiopathology , Vital Capacity/drug effects , Adolescent , Adult , Aged , Dyspnea/complications , Dyspnea/drug therapy , Dyspnea/physiopathology , Female , Humans , Male , Middle Aged , Potassium/therapeutic use , Pulmonary Diffusing Capacity/drug effects , Pulmonary Fibrosis/complications , Pulmonary Fibrosis/physiopathology , Respiratory Sounds/drug effects , Retrospective Studies , Scleroderma, Systemic/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...